toosendanin

[(1S,2R,4R,5R,6S,8R,10S,11S,12R,14R,15R,16R,19S,21R)-4-acetyloxy-6-(uran-3-yl)-12,16,19-trihydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.01,14.02,11.05,10.08,10]henicosan-21-yl] acetate

NAHTXVIXCMUDLF-RFNFAWMESA-N CHEBI:192461 0 Reactome links 1 studies
1 Observed studies
1 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
NAHTXVIXCMUDLF-RFNFAWMESA-N
IUPAC name
[(1S,2R,4R,5R,6S,8R,10S,11S,12R,14R,15R,16R,19S,21R)-4-acetyloxy-6-(uran-3-yl)-12,16,19-trihydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.01,14.02,11.05,10.08,10]henicosan-21-yl] acetate
Preferred name
toosendanin
INN name
Synonym
ChEBI
CHEBI:192461

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles